Elsevier

Cellular Immunology

Volume 118, Issue 1, January 1989, Pages 108-125
Cellular Immunology

The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus

https://doi.org/10.1016/0008-8749(89)90361-4Get rights and content

Abstract

The surface of dendritic cells from mouse spleen, thymus, and epidermis has been compared with a panel of monoclonal antibodies and the FACS. A method was first developed to isolate populations of large, adherent, thymic dendritic cells that were > 90% pure. These were released by collagenase digestion and separated from adherent macrophages after overnight culture. Enrichment was based on the facts that most macrophages remained plastic adherent and rosetted strongly with antibody-coated erythrocytes. As in spleen, thymic dendritic cells were stellate in shape, had abundant class I and II MHC products, lacked many standard macrophage and lymphocyte markers, and actively stimulated the mixed leukocyte reaction. Most spleen and thymic dendritic cells could be lysed by the 7D4 mAb, to the low-affinity IL-2 receptor, and complement but the levels of 7D4 by FACS were low and sometimes not above background. Differences among dendritic cells from different tissues were noted with other mAb. Adherent dendritic cells from thymus all expressed the J11d “B cell” antigen and the NL145 interdigitating cell marker, but lacked the 33D1 spleen dendritic cell antigen. Eighty to ninety percent of spleen dendritic cells were J11d, NL145, 33D1+ but the remainder expressed the J11d+, NL145+, 33D1 thymic phenotype. The latter phenotype also was identical to that of epidermal Langerhans' cells. We postulate that the major 33D1+ cell in spleen represents a migratory stage in which dendritic cells are moving from tissues to lymphoid organs.

References (28)

  • M.D. Witmer-Pack et al.

    J. Invest. Dermatol

    (1988)
  • T.W. Wong et al.

    Immunobiology

    (1982)
  • R.A. Pereira et al.

    Cell. Immunol

    (1986)
  • S. Fossum et al.

    Immunobiology

    (1984)
  • M.C. Nussenzweig et al.

    J. Exp. Med

    (1981)
  • R.M. Steinman et al.

    Transplant. Proc

    (1983)
  • C.W. Pugh et al.

    J. Exp. Med

    (1983)
  • R.M. Steinman et al.

    J. Exp. Med

    (1979)
  • R.M. Steinman et al.
  • M.D. Witmer-Pack et al.

    J. Exp. Med

    (1987)
  • K. Inaba et al.

    J. Exp. Med

    (1988)
  • R.M. Steinman et al.

    J. Exp. Med

    (1974)
  • A. Marshak-Rothstein et al.

    J. Immunol

    (1979)
  • R.L. Coffman et al.

    Nature (London)

    (1981)
  • Cited by (305)

    • Transcriptional Control of Dendritic Cell Development

      2013, Advances in Immunology
      Citation Excerpt :

      Newly differentiated cDCs exist in an immature state where they exhibit high endocytic activity but low surface MHC class I and II proteins, but on encountering microbial or inflammatory stimuli, transport peptide–MHC complexes to their cell surface, and induce costimulatory molecules and chemokine receptors directing their migration to lymphoid tissues (Inaba et al., 2000; Mellman & Steinman, 2001; Pierre et al., 1997). Originally considered homogeneous, studies from Steinman (Crowley, Inaba, Witmer-Pack, & Steinman, 1989) and Shortman (Ardavin & Shortman, 1992; Vremec et al., 1992) identified subsets of cDCs based on differential CD8-α expression. Later, a CD4+ cDC subset was identified in lymphoid organs (Shortman & Liu, 2002; Vremec, Pooley, Hochrein, Wu, & Shortman, 2000).

    View all citing articles on Scopus

    Supported by Grant AI 13013 from the NIH.

    View full text